Patent ID: 11938177
Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  B | IPC A  B

Claim 8:
9. The immunogenic composition of claim 1, wherein:
(a) the first polymer is a sodium alginate polymer, and a negative to positive charge ratio of the net charge of the conjugate to the net charge of the first polymer is from about 5:1 to about 2:1 mol/mol, or from about 1:10 to about 1:20 mol/mol;
(b) the first polymer is a nucleic acid polymer, and a negative to positive charge ratio of the net charge of the conjugate to the net charge of the first polymer is from about 5:1 to about 2:1 mol/mol, or from about 1:10 to about 1:20 mol/mol; or
(c) the first polymer is a poly(methacrylic acid) polymer, and a negative to positive charge ratio of the net charge of the conjugate to the net charge of the first polymer is from about 1:5 to about 1:10 mol/mol;
(d) the first polymer is a poly(L-glutamic acid) polymer, and a negative to positive charge ratio of the net charge of the conjugate to the net charge of the first polymer is from about 1:5 to about 1:10 mol/mol.